Catalyst
Slingshot members are tracking this event:
The Prescription Drug User Fee Act (PDUFA) date for DSUVIA in Moderate-To-Severe Acute Pain Management set for November 3, 2018
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
ACRX | Community voting in process |
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 02, 2018
Occurred Source:
http://ir.acelrx.com/news-releases/news-release-details/acelrx-announces-fda-approval-dsuviatm
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Dsuvia, Pdufa